Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 296, Issue 6, 2009, Pages

  Takeuchi, Kazuharu ^a   Reue, Karen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1 acylglycerol 3 phosphate acyltransferase; Glycerol 3 phosphate acyltransferase; Phosphatidate phosphatase

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 1; 1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE 2; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 1; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 2; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 3; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LIPIN 1; LIPIN 2; LIPIN 3; MESSENGER RNA; PHOSPHATIDATE PHOSPHATASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELL METABOLISM; CONGENITAL GENERALIZED LIPODYSTROPHY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; FATTY LIVER; GENE ACTIVITY; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; INFLAMMATORY DISEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIPOGENESIS; MAJEED SYNDROME; MUSCLE CELL; MYOGLOBINURIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; ADIPOCYTES; ANIMALS; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; HUMANS; MUSCLE CELLS; PHOSPHATIDATE PHOSPHATASE; TRIGLYCERIDES;

EID: 66849089697     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90958.2008     Document Type: Review

References (127)

1. Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, Barnes RI, Garg A. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 31: 21-23, 2002. (Pubitemid 34887633)
2. Agarwal AK, Barnes RI, Garg A. Functional characterization of human 1-acylglycerol-3-phosphate acyltransferase isoform 8: cloning, tissue distribution, gene structure, and enzymatic activity. Arch Biochem Biophys 449: 64-76, 2006.
3. Agarwal AK, Garg A. Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol Metab 14: 214-221, 2003. (Pubitemid 36841479)
4. Agarwal AK, Garg A. Genetic basis of lipodystrophies and management of metabolic complications. Annu Rev Med 57: 297-311, 2006. (Pubitemid 43261993)
5. Agarwal AK, Garg A. Genetic disorders of adipose tissue development, differentiation, and death. Annu Rev Genomics Hum Genet 7: 175-199, 2006. (Pubitemid 44627927)
6. Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, O'Rahilly S, Zaidi Z, Gurakan F, Arslanian SA, Klar A, Ricker A, White NH, Bindl L, Herbst K, Kennel K, Patel SB, Al-Gazali L, Garg A. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab 88: 4840-4847, 2003. (Pubitemid 37357534)
7. Agarwal AK, Sukumaran S, Bartz R, Barnes RI, Garg A. Functional characterization of human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 9: cloning, tissue distribution, gene structure, and enzymatic activity. J Endocrinol 193: 445-457, 2007. (Pubitemid 47028695)
8. Aguado B, Campbell RD. Characterization of a human lysophosphatidic acid acyltransferase that is encoded by a gene located in the class III region of the human major histocompatibility complex. J Biol Chem 273: 4096-4105, 1998. (Pubitemid 28103277)
9. Al-Mosawi ZS, Al-Saad KK, Ijadi-Maghsoodi R, El-Shanti HI, Ferguson PJ. A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis Rheum 56: 960-964, 2007. (Pubitemid 46399443)
10. Aulchenko YS, Pullen J, Kloosterman WP, Yazdanpanah M, Hofman A, Vaessen N, Snijders PJ, Zubakov D, Mackay I, Olavesen M, Sidhu B, Smith VE, Carey A, Berezikov E, Uitterlinden AG, Plasterk RH, Oostra BA, van Duijn CM. LPIN2 is associated with type 2 diabetes, glucose metabolism, and body composition. Diabetes 56: 3020-3026, 2007. (Pubitemid 350223638)
11. Beigneux AP, Vergnes L, Qiao X, Quatela S, Davis R, Watkins SM, Coleman RA, Walzem RL, Philips M, Reue K, Young SG. Agpat6 - a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium. J Lipid Res 47: 734-744, 2006.
12. Borkenhagen LF, Kennedy EP. The enzymatic synthesis of cytidine diphosphate choline. J Biol Chem 227: 951-962, 1957.
13. Brindley DN. Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer. J Cell Biochem 92: 900-912, 2004. (Pubitemid 44264240)
14. Brindley DN. Phosphatidate Phosphohydrolase: Its Role in Glycerolipid Synthesis. Boca Raton, FL: CRC, 1988, p. 21-77.
15. Brindley DN, Pilquil C, Sariahmetoglu M, Reue K. Phosphatidate degradation: Phosphatidate phosphatases (lipins) and lipid phosphate phosphatases. Biochim Biophys Acta. In press.
16. Bronnikov GE, Aboulaich N, Vener AV, Stralfors P. Acute effects of insulin on the activity of mitochondrial GPAT1 in primary adipocytes. Biochem Biophys Res Commun 367: 201-207, 2008.
17. Cao J, Li JL, Li D, Tobin JF, Gimeno RE. Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis. Proc Natl Acad Sci USA 103: 19695-19700, 2006. (Pubitemid 46037494)
18. Cao J, Liu Y, Lockwood J, Burn P, Shi Y. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J Biol Chem 279: 31727-31734, 2004. (Pubitemid 39037844)
19. Carman GM, Han GS. Phosphatidic acid phosphatase, a key enzyme in the regulation of lipid synthesis. J Biol Chem 284: 2593-2597, 2009.
20. Carman GM, Han GS. Roles of phosphatidate phosphatase enzymes in lipid metabolism. Trends Biochem Sci 31: 694-699, 2006. (Pubitemid 44791946)
21. Cha JY, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 282: 743-751, 2007. (Pubitemid 47076632)
22. Chen X, Hyatt BA, Mucenski ML, Mason RJ, Shannon JM. Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells. Proc Natl Acad Sci USA 103: 11724-11729, 2006. (Pubitemid 44182518)
23. Chen YQ, Kuo MS, Li S, Bui HH, Peake DA, Sanders PE, Thibodeaux SJ, Chu S, Qian YW, Zhao Y, Bredt DS, Moller DE, Konrad RJ, Beigneux AP, Young SG, Cao G. AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase. J Biol Chem 283: 10048-10057, 2008.
24. Coleman RA, Lee DP. Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res 43: 134-176, 2004. (Pubitemid 37492937)
25. Coon M, Ball A, Pound J, Ap S, Hollenback D, White T, Tulinsky J, Bonham L, Morrison DK, Finney R, Singer JW. Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells. Mol Cancer Ther 2: 1067-1078, 2003.
26. Cortes VA, Curtis DE, Sukumaran S, Shao X, Parameswara V, Rashid S, Smith AR, Ren J, Esser V, Hammer RE, Agarwal AK, Horton JD, Garg A. Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metab 9: 165-176, 2009.
27. Croce MA, Eagon JC, LaRiviere LL, Korenblat KM, Klein S, Finck BN. Hepatic lipin-1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss. Diabetes 56: 2395-2399, 2007. (Pubitemid 47358247)
28. Diefenbach CS, Soslow RA, Iasonos A, Linkov I, Hedvat C, Bonham L, Singer J, Barakat RR, Aghajanian C, Dupont J. Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival. Cancer 107: 1511-1519, 2006. (Pubitemid 44546911)
29. Donkor J, Sariahmetoglu M, Dewald J, Brindley DN, Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J Biol Chem 282: 3450-3457, 2007. (Pubitemid 47084457)
30. Donkor J, Sparks LM, Xie H, Smith SR, Reue K. Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J Clin Endocrinol Metab 93: 233-239, 2008.
31. Douvas MG, Hogan KN, Ji Y, Hollenback D, Bonham L, Singer JW, Mitchell BS. Effect of lysophosphatidic acid acyltransferase-beta inhibition in acute leukemia. Leuk Res 30: 1027-1036, 2006. (Pubitemid 43831183)
32. Eberhardt C, Gray PW, Tjoelker LW. cDNA cloning, expression and chromosomal localization of two human lysophosphatidic acid acyltransferases. Adv Exp Med Biol 469: 351-356, 1999.
33. Eberhardt C, Gray PW, Tjoelker LW. Human lysophosphatidic acid acyltransferase. cDNA cloning, expression, and localization to chromosome 9q343. J Biol Chem 272: 20299-20305, 1997. (Pubitemid 27340144)
34. Ebihara K, Kusakabe T, Hirata M, Masuzaki H, Miyanaga F, Kobayashi N, Tanaka T, Chusho H, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y, DePaoli AM, Fukushima M, Nakao K. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab 92: 532-541, 2007. (Pubitemid 46255292)
35. Fawcett KA, Grimsey N, Loos RJ, Wheeler E, Daly A, Soos M, Semple R, Syddall H, Cooper C, Siniossoglou S, O'Rahilly S, Wareham NJ, Barroso I. Evaluating the role of LPIN1 variation in insulin resistance, body weight, and human lipodystrophy in U.K. Populations. Diabetes 57: 2527-2533, 2008.
36. Ferguson PJ, Chen S, Tayeh MK, Ochoa L, Leal SM, Pelet A, Munnich A, Lyonnet S, Majeed HA, El-Shanti H. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42: 551-557, 2005. (Pubitemid 40993830)
37. Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence JC Jr, Kelly DP. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab 4: 199-210, 2006. (Pubitemid 44283957)
38. Gale SE, Frolov A, Han X, Bickel PE, Cao L, Bowcock A, Schaffer JE, Ory DS. A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation. J Biol Chem 281: 11082-11089, 2006. (Pubitemid 43855532)
39. Gimeno RE, Cao J. Thematic review series: glycerolipids. Mammalian glycerol-3-phosphate acyltransferases: new genes for an old activity. J Lipid Res 49: 2079-2088, 2008.
40. Gomes KB, Pardini VC, Ferreira AC, Fernandes AP. Phenotypic heterogeneity in biochemical parameters correlates with mutations in AGPAT2 or Seipin genes among Berardinelli-Seip congenital lipodystrophy patients. J Inherit Metab Dis 28: 1123-1131, 2005. (Pubitemid 43168949)
41. Gomez-Muñoz A, Hamza EH, Brindley DN. Effects of sphingosine, albumin and unsaturated fatty acids on the activation and translocation of phosphatidate phosphohydrolases in rat hepatocytes. Biochim Biophys Acta 1127: 49-56, 1992.
42. Gonzalez-Baró MR, Lewin TM, Coleman RA. Regulation of Triglyceride Metabolism II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin action. Am J Physiol Gastrointest Liver Physiol 292: G1195-G1199, 2007. (Pubitemid 47084642)
43. Grimsey N, Han GS, O'Hara L, Rochford JJ, Carman GM, Siniossoglou S. Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2. J Biol Chem 283: 29166-29174, 2008.
44. Hammond LE, Albright CD, He L, Rusyn I, Watkins SM, Doughman SD, Lemasters JJ, Coleman RA. Increased oxidative stress is associated with balanced increases in hepatocyte apoptosis and proliferation in glycerol-3-phosphate acyltransferase-1 deficient mice. Exp Mol Pathol 82: 210-219, 2007. (Pubitemid 46505131)
45. Hammond LE, Gallagher PA, Wang S, Hiller S, Kluckman KD, Posey-Marcos EL, Maeda N, Coleman RA. Mitochondrial glycerol-3-phosphate acyltransferase- deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol Cell Biol 22: 8204-8214, 2002. (Pubitemid 35304054)
46. Hammond LE, Neschen S, Romanelli AJ, Cline GW, Ilkayeva OR, Shulman GI, Muoio DM, Coleman RA. Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs. J Biol Chem 280: 25629-25636, 2005. (Pubitemid 40962271)
47. Han GS, Siniossoglou S, Carman GM. The cellular functions of the yeast lipin homolog PAH1p are dependent on its phosphatidate phosphatase activity. J Biol Chem 282: 37026-37035, 2007.
48. Han GS, Wu WI, Carman GM. The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme. J Biol Chem 281: 9210-9218, 2006. (Pubitemid 43864636)
49. Haque W, Garg A, Agarwal AK. Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy. Biochem Biophys Res Commun 327: 446-453, 2005. (Pubitemid 40040496)
50. Haque WA, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87: 2395, 2002. (Pubitemid 34521536)
51. Harada N, Hara S, Yoshida M, Zenitani T, Mawatari K, Nakano M, Takahashi A, Hosaka T, Yoshimoto K, Nakaya Y. Molecular cloning of a murine glycerol-3-phosphate acyltransferase-like protein 1 (xGPAT1). Mol Cell Biochem 297: 41-51, 2007. (Pubitemid 46443528)
52. Harris TE, Huffman TA, Chi A, Shabanowitz J, Hunt DF, Kumar A, Lawrence JC Jr. Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J Biol Chem 282: 277-286, 2007. (Pubitemid 47076630)
53. Heath RJ, Rock CO. A conserved histidine is essential for glycerolipid acyltransferase catalysis. J Bacteriol 180: 1425-1430, 1998. (Pubitemid 28125725)
54. Hegele RA, Joy TR, Al-Attar SA, Rutt BK. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res 48: 1433-1444, 2007. (Pubitemid 47312005)
55. Hideshima T, Chauhan D, Ishitsuka K, Yasui H, Raje N, Kumar S, Podar K, Mitsiades C, Hideshima H, Bonham L, Munshi NC, Richardson PG, Singer JW, Anderson KC. Molecular characterization of PS-341 (bortezomib) resistance: implications for overcoming resistance using lysophosphatidic acid acyltransferase (LPAAT)-beta inhibitors. Oncogene 24: 3121-3129, 2005. (Pubitemid 40695081)
56. Hollenback D, Bonham L, Law L, Rossnagle E, Romero L, Carew H, Tompkins CK, Leung DW, Singer JW, White T. Substrate specificity of lysophosphatidic acid acyltransferase beta - evidence from membrane and whole cell assays. J Lipid Res 47: 593-604, 2006. (Pubitemid 43345600)
57. Huffman TA, Mothe-Satney I, Lawrence JC Jr. Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc Natl Acad Sci USA 99: 1047-1052, 2002. (Pubitemid 34106633)
58. Iqbal J, Hussain M. Intestinal lipid absorption. Am J Physiol Endocrinol Metab (January 21, 2009). doi:10.1152/ajpendo.90899.2008.
59. Johnston JM, Paultauf F, Schiller CM, Schultz LD. The utilization of the alpha-glycerophosphate and monoglyceride pathways for phosphatidyl choline biosynthesis in the intestine. Biochim Biophys Acta 218: 124-133, 1970.
60. Kang ES, Park SE, Han SJ, Kim SH, Nam CM, Ahn CW, Cha BS, Kim KS, Lee HC. LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients. Mol Genet Metab 95: 96-100, 2008.
61. Kennedy EP. Biosynthesis of complex lipids. Fed Proc 20: 934-940, 1961.
62. Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipids. J Biol Chem 222: 193-214, 1956.
63. Koh YK, Lee MY, Kim JW, Kim M, Moon JS, Lee YJ, Ahn YH, Kim KS. Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2. J Biol Chem 283: 34896-34906, 2008.
64. Kume K, Shimizu T. cDNA cloning and expression of murine 1-acyl-sn-glycerol-3-phosphate acyltransferase. Biochem Biophys Res Commun 237: 663-666, 1997. (Pubitemid 27434744)
65. La Rosée P, Jia T, Demehri S, Härtel N, de Vries P, Bonham L, Hollenback D, Singer JW, Melo JV, Druker BJ, Deininger MW. Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib. Clin Cancer Res 12: 6540-6546, 2006. (Pubitemid 44799729)
66. Langner CA, Birkenmeier EH, Roth KA, Bronson RT, Gordon JI. Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. J Biol Chem 266: 11955-11964, 1991. (Pubitemid 21907042)
67. Langner CA, Brikenmeier EH, Ben-Zeev O, Schotz MC, Sweet HO, Davisson MT, Gordon JI. The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J Biol Chem 264: 7994-8003, 1989. (Pubitemid 19137280)
68. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51, 2004. (Pubitemid 38076464)
69. Leung DW. The structure and functions of human lysophosphatidic acid acyltransferases. Front Biosci 6: D944-D953, 2001.
70. Lewin TM, Schwerbrock NM, Lee DP, Coleman RA. Identification of a new glycerol-3-phosphate acyltransferase isoenzyme, mtGPAT2, in mitochondria. J Biol Chem 279: 13488-13495, 2004. (Pubitemid 38468873)
71. Lewin TM, Wang S, Nagle CA, Van Horn CG, Coleman RA. Mitochondrial glycerol-3-phosphate acyltransferase-1 directs the metabolic fate of exogenous fatty acids in hepatocytes. Am J Physiol Endocrinol Metab 288: E835-E844, 2005. (Pubitemid 40547875)
72. Li D, Yu L, Wu H, Shan Y, Guo J, Dang Y, Wei Y, Zhao S. Cloning and identification of the human LPAAT-zeta gene, a novel member of the lysophosphatidic acid acyltransferase family. J Hum Genet 48: 438-442, 2003. (Pubitemid 37221560)
73. Lindén D, William-Olsson L, Ahnmark A, Ekroos K, Hallberg C, Sjögren HP, Becker B, Svensson L, Clapham JC, Oscarsson J, Schreyer S. Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation. FASEB J 20: 434-443, 2006. (Pubitemid 44933320)
74. Lindén D, William-Olsson L, Rhedin M, Asztély AK, Clapham JC, Schreyer S. Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis. J Lipid Res 45: 1279-1288, 2004. (Pubitemid 38802631)
75. Loos RJ, Rankinen T, Pérusse L, Tremblay A, Després JP, Bouchard C. Association of lipin 1 gene polymorphisms with measures of energy and glucose metabolism. Obesity 15: 2723-2732, 2007.
76. Lu B, Jiang YJ, Man MQ, Brown B, Wlias PM, Feingold KR. Expression and regulation of 1-acyl-sn-glycerol- 3-phosphate acyltransferases in the epidermis. J Lipid Res 46: 2448-2457, 2005. (Pubitemid 41532533)
77. Lu B, Jiang YJ, Zhou Y, Xu FY, Hatch GM, Choy PC. Cloning and characterization of murine 1-acyl-sn-glycerol 3-phosphate acyltransferases and their regulation by PPARalpha in murine heart. Biochem J 385: 469-477, 2005. (Pubitemid 40165080)
78. Manmontri B, Sariahmetoglu M, Donkor J, Bou Khalil M, Sundaram M, Yao Z, Reue K, Lehner R, Brindley DN. Glucocorticoids and cAMP selectively increase hepatic lipin-1 expression and insulin acts antagonistically. J Lipid Res 49: 1056-1067, 2008.
79. Martin PG, Guillou H, Lasserre F, Déjean S, Lan A, Pascussi JM, Sancristobal M, Legrand P, Besse P, Pineau T. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study. Hepatology 45: 767-777, 2007. (Pubitemid 46450628)
80. Nadra K, de Preux Charles AS, Médard JJ, Hendriks WT, Han GS, Grès S, Carman GM, Saulnier-Blache JS, Verheijen MH, Chrast R. Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes Dev 22: 1647-1661, 2008.
81. Nagle CA, An J, Shiota M, Torres TP, Cline GW, Liu ZX, Wang S, Catlin RL, Shulman GI, Newgard CB, Coleman RA. Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance. J Biol Chem 282: 14807-14815, 2007.
82. Nagle CA, Vergnes L, Dejong H, Wang S, Lewin TM, Reue K, Coleman RA. Identification of a novel sn-glycerol-3-phosphate acyltransferase isoform, GPAT4, as the enzyme deficient in Agpat6-/- mice. J Lipid Res 49: 823-831, 2008.
83. Nakanishi H, Shindou H, Hishikawa D, Harayama T, Ogasawara R, Suwabe A, Taguchi R, Shimizu T. Cloning and characterization of mouse lung-type acyl-CoA:lysophosphatidylcholine acyltransferase 1 (LPCAT1). Expression in alveolar type II cells and possible involvement in surfactant production. J Biol Chem 281: 20140-20147, 2006. (Pubitemid 44065788)
84. Neschen S, Morino K, Hammond LE, Zhang D, Liu ZX, Romanelli AJ, Cline GW, Pongratz RL, Zhang XM, Choi CS, Coleman RA, Shulman GI. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn- 3-phosphate acyltransferase 1 knockout mice. Cell Metab 2: 55-65, 2005. (Pubitemid 43239825)
85. Niesporek S, Denkert C, Weichert W, Köbel M, Noske A, Sehouli J, Singer JW, Dietel M, Hauptmann S. Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis. Br J Cancer 92: 1729-1736, 2005. (Pubitemid 40756485)
86. Oishi K, Amagai N, Shirai H, Kadota K, Ohkura N, Ishida N. Genome-wide expression analysis reveals 100 adrenal gland-dependent circadian genes in the mouse liver. DNA Res 12: 191-202, 2005.
87. Ong KL, Leung RY, Wong LY, Cherny SS, Sham PC, Lam TH, Lam KS, Cheung BM. Association of a polymorphism in the lipin 1 gene with systolic blood pressure in men. Am J Hypertens 21: 539-545, 2008.
88. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A. Leptin-replacement therapy for lipodystrophy. N Engl J Med 346: 570-578, 2002. (Pubitemid 34438818)
89. Pagel JM, Laugen C, Bonham L, Hackman RC, Hockenbery DM, Bhatt R, Hollenback D, Carew H, Singer JW, Press OW. Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas. Clin Cancer Res 11: 4857-4866, 2005. (Pubitemid 41557206)
90. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109: 307-320, 2002. (Pubitemid 34606874)
91. Pellon-Maison M, Coleman RA, Gonzalez-Baró MR. The C-terminal region of mitochondrial glycerol-3-phosphate acyltransferase-1 interacts with the active site region and is required for activity. Arch Biochem Biophys 450: 157-166, 2006. (Pubitemid 43849622)
92. Peterfy M, Phan J, Reue K. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J Biol Chem 280: 32883-32889, 2005. (Pubitemid 41368337)
93. Peterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet 27: 121-124, 2001. (Pubitemid 32044532)
94. Phan J, Peterfy M, Reue K. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J Biol Chem 279: 29558-29564, 2004. (Pubitemid 38915837)
95. Phan J, Reue K. Lipin, a lipodystrophy and obesity gene. Cell Metab 1: 73-83, 2005. (Pubitemid 43960586)
96. Reue K, Brindley DN. Thematic Review Series: Glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism. J Lipid Res 49: 2493-2503, 2008.
97. Reue K, Dwyer JR. Lipin proteins and metabolic homeostasis. J Lipid Res. In press.
98. Reue K, Xu P, Wang XP, Slavin BG. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J Lipid Res 41: 1067-1076, 2000. (Pubitemid 30483010)
99. Reue K, Zhang P. The lipin protein family: dual roles in lipid biosynthesis and gene expression. FEBS Lett 582: 90-96, 2008.
100. Ruan H, Pownall HJ. Overexpression of 1-acyl-glycerol-3-phosphate acyltransferase-alpha enhances lipid storage in cellular models of adipose tissue and skeletal muscle. Diabetes 50: 233-240, 2001. (Pubitemid 32127277)
101. Shi Y, Cheng D. Beyond Triglyceride Synthesis: The Dynamic Functional Roles of MGAT and DGAT Enzymes in Energy Metabolism. Am J Physiol Endocrinol Metab (December 30, 2008). doi:10.1152/ajpendo.90949.2008.
102. Shindou H, Hishikawa D, Harayama T, Yuki K, Shimizu T. Recent progress on acyl-CoA:lysophospholipid acyltransferase research. J Lipid Res. In press.
103. Simha V, Garg A. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes. J Clin Endocrinol Metab 88: 5433-5437, 2003. (Pubitemid 37452750)
104. Soupene E, Fyrst H, Kuypers FA. Mammalian acyl-CoA: lysophosphatidylcholine acyltransferase enzymes. Proc Natl Acad Sci USA 105: 88-93, 2008.
105. Springett GM, Bonham L, Hummer A, Linkov I, Misra D, Ma C, Pezzoni G, Di Giovine S, Singer J, Kawasaki H, Spriggs D, Soslow R, Dupont J. Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies. Cancer Res 65: 9415-9425, 2005. (Pubitemid 41508010)
106. Stamps AC, Elmore MA, Hill ME, Kelly K, Makda AA, Finnen MJ. A human cDNA sequence with homology to non-mammalian lysophosphatidic acid acyltransferases. Biochem J 326: 455-461, 1997. (Pubitemid 27417223)
107. Sukumaran S, Barnes R, Garg A, Agarwal A. Functional characterization of the human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 10 / glycerol-3-phosphate acyltransferase isoform 3 (AGPAT10/GPAT3). J Mol Endocrinol. In press.
108. Suviolahti E, Reue K, Cantor RM, Phan J, Gentile M, Naukkarinen J, Soro-Paavonen A, Oksanen L, Kaprio J, Rissanen A, Salomaa V, Kontula K, Taskinen MR, Pajukanta P, Peltonen L. Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism. Hum Mol Genet 15: 377-386, 2006. (Pubitemid 43159890)
109. Tang W, Yuan J, Chen X, Gu X, Luo K, Li J, Wan B, Wang Y, Yu L. Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway. J Biochem Mol Biol 39: 626-635, 2006. (Pubitemid 44714544)
110. Turkish A, Sturley SL. Regulation of Triglyceride Metabolism. I. Eukaryotic neutral lipid synthesis: "Many ways to skin ACAT or a DGAT". Am J Physiol Gastrointest Liver Physiol 292: G953-G957, 2007.
111. Turnbull AP, Rafferty JB, Sedelnikova SE, Slabas AR, Schierer TP, Kroon JT, Simon JW, Fawcett T, Nishida I, Murata N, Rice DW. Analysis of the structure, substrate specificity, and mechanism of squash glycerol-3-phosphate (1)-acyltransferase. Structure 9: 347-353, 2001. (Pubitemid 32497262)
112. van Harmelen V, Rydén M, Sjölin E, Hoffstedt J. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. J Lipid Res 48: 201-206, 2007. (Pubitemid 46052912)
113. Vancura A, Haldar D. Purification and characterization of glycerophosphate acyltransferase from rat liver mitochondria. J Biol Chem 27209-27215, 1994. (Pubitemid 24346536)
114. Vergnes L, Beigneux AP, Davis R, Watkins SM, Young SG, Reue K. Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J Lipid Res 47: 745-754, 2006.
115. Waki H, Park KW, Mitro N, Pei L, Damoiseaux R, Wilpitz DC, Reue K, Saez E, Tontonoz P. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. Cell Metab 5: 357-370, 2007. (Pubitemid 46667757)
116. Wang S, Lee DP, Gong N, Schwerbrock NM, Mashek DG, Gonzalez-Baró MR, Stapleton C, Li LO, Lewin TM, Coleman RA. Cloning and functional characterization of a novel mitochondrial N-ethylmaleimide-sensitive glycerol-3-phosphate acyltransferase (GPAT2). Arch Biochem Biophys 465: 347-358, 2007. (Pubitemid 47361998)
117. West J, Tompkins CK, Balantac N, Nudelman E, Meengs B, White T, Bursten S, Coleman J, Kumar A, Singer JW, Leung DW. Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells. DNA Cell Biol 16: 691-701, 1997. (Pubitemid 27276833)
118. Wiedmann S, Fischer M, Koehler M, Neureuther K, Riegger G, Doering A, Schunkert H, Hengstenberg C, Baessler A. Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes 57: 209-217, 2008.
119. Xu H, Wilcox D, Nguyen P, Voorbach M, Suhar T, Morgan SJ, An WF, Ge L, Green J, Wu Z, Gimeno RE, Reilly R, Jacobson PB, Collins CA, Landschulz K, Surowy T. Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile. Biochem Biophys Res Commun 349: 439-448, 2006.
120. Xu J, Lee WN, Phan J, Saad MF, Reue K, Kurland IJ. Lipin deficiency impairs diurnal metabolic fuel switching. Diabetes 55: 3429-3438, 2006. (Pubitemid 44923602)
121. Yamashita A, Kawagishi N, Miyashita T, Nagatsuka T, Sugiura T, Kume K, Shimizu T, Waku K. ATP-independent fatty acyl-coenzyme A synthesis from phospholipid: coenzyme A-dependent transacylation activity toward lysophosphatidic acid catalyzed by acyl-coenzyme A: lysophosphatidic acid acyltransferase. J Biol Chem 276: 26745-26752, 2001. (Pubitemid 37410571)
122. Yamashita A, Nakanishi H, Suzuki H, Kamata R, Tanaka K, Waku K, Sugiura T. Topology of acyltransferase motifs and substrate specificity and accessibility in 1-acyl-sn-glycero-3-phosphate acyltransferase 1. Biochim Biophys Acta 1771: 1202-1215, 2007. (Pubitemid 47404973)
123. Yao-Borengasser A, Rasouli N, Varma V, Miles LM, Phanavanh B, Starks TN, Phan J, Spencer HJ 3rd, McGehee RE Jr, Reue K, Kern PA. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes 55: 2811-2818, 2006. (Pubitemid 44923681)
124. Ye GM, Chen C, Huang S, Han DD, Guo JH, Wan B, Yu L. Cloning and characterization a novel human 1-acyl-sn-glycerol-3-phosphate acyltransferase gene AGPAT7. DNA Seq 16: 386-390, 2005. (Pubitemid 44567645)
125. Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV Jr. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 49: 2283-2301, 2008.
126. Zeharia A, Shaag A, Houtkooper RH, Hindi T, de Lonlay P, Erez G, Hubert L, Saada A, de Keyzer Y, Eshel G, Vaz FM, Pines O, Elpeleg O. Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Am J Hum Genet 83: 1-6, 2008.
127. Zhang P, O'Loughlin L, Brindley DN, Reue K. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J Lipid Res 49: 1519-1528, 2008.